Drug companies try to catch the rising wave of RNAi medicines - STAT

Drug companies try to catch the rising wave of RNAi medicines - STAT

STAT Plus: Drug companies try to catch the rising wave of RNAi medicines

By KATE SHERIDAN

NIH

Within the last month, Eli Lilly, Alexion, and Janssen have all announced licensing and collaboration deals with companies developing RNAi treatments.

READ MORE